NKGen Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.08	0.03	0.12	0.35
Cash & Short-Term Investments	0.08	0.03	0.12	0.35
Cash Growth	-93.54%	-77.78%	-66.67%	-
Accounts Receivable	-	-	0.03	-
Other Receivables	0.02	0.03	0.07	0.07
Receivables	0.02	0.03	0.1	0.07
Prepaid Expenses	0.87	1.57	0.13	0.17
Restricted Cash	0.25	0.25	-	-
Other Current Assets	0.02	0.06	0	0.02
Total Current Assets	1.25	1.93	0.35	0.61
Property, Plant & Equipment	14.31	14.46	15.88	17.37
Other Intangible Assets	0.09	0.09	0.1	0.09
Total Assets	15.65	16.48	16.33	18.07
Accounts Payable	12.69	11.04	0.98	1.69
Accrued Expenses	2.3	2.27	1.65	0.49
Short-Term Debt	17.25	9.99	11.66	51.15
Current Portion of Leases	0.15	-	0.38	0.46
Other Current Liabilities	19.01	16.15	0.08	1.96
Total Current Liabilities	51.41	39.45	14.74	55.74
Long-Term Debt	10.37	9.93	-	-
Long-Term Leases	0.32	-	-	0.36
Long-Term Deferred Tax Liabilities	0.03	0.03	0.03	0.02
Other Long-Term Liabilities	23.24	25.76	-	-
Total Liabilities	85.37	75.17	14.77	56.12
Common Stock	0	0	0	0.01
Additional Paid-In Capital	124.59	121.73	80.74	14.36
Retained Earnings	-183.6	-162.13	-79.18	-52.42
Comprehensive Income & Other	-10.71	-18.29	-	-
Shareholders' Equity	-69.72	-58.69	1.56	-38.05
Total Liabilities & Equity	15.65	16.48	16.33	18.07
Total Debt	28.09	19.92	12.03	51.97
Net Cash (Debt)	-28.01	-19.9	-11.92	-51.62
Net Cash Per Share	-1.38	-1.29	-1.87	-3.62
Filing Date Shares Outstanding	35.36	22.81	32.6	14.25
Total Common Shares Outstanding	25.77	21.89	32.58	14.25
Working Capital	-50.16	-37.52	-14.39	-55.13
Book Value Per Share	-2.71	-2.68	0.05	-2.67
Tangible Book Value	-69.81	-58.79	1.47	-38.14
Tangible Book Value Per Share	-2.71	-2.69	0.05	-2.68
Land	5.03	5.03	5.03	5.03
Buildings	8.33	8.33	8.33	8.31
Machinery	4.8	4.88	4.81	4.71
Leasehold Improvements	0.05	0.05	0.05	0.05

Source: S&P Capital IQ. Standard template. Financial Sources.